Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Intangibles (2023 - 2025)

Perspective Therapeutics' Intangibles history spans 6 years, with the latest figure at $50.0 million for Q3 2025.

  • For Q3 2025, Intangibles changed 0.0% year-over-year to $50.0 million; the TTM value through Sep 2025 reached $50.0 million, changed 0.0%, while the annual FY2024 figure was $50.0 million, 0.0% changed from the prior year.
  • Intangibles for Q3 2025 was $50.0 million at Perspective Therapeutics, roughly flat from $50.0 million in the prior quarter.
  • Across five years, Intangibles topped out at $50.0 million in Q1 2023 and bottomed at $50.0 million in Q1 2023.
  • The 3-year median for Intangibles is $50.0 million (2023), against an average of $50.0 million.
  • The largest YoY upside for Intangibles was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Intangibles shows it stood at $50.0 million in 2023, then changed by 0.0% to $50.0 million in 2024, then changed by 0.0% to $50.0 million in 2025.
  • Per Business Quant, the three most recent readings for CATX's Intangibles are $50.0 million (Q3 2025), $50.0 million (Q2 2025), and $50.0 million (Q1 2025).